Celularity Inc.
CELU
$2.02
$0.000.00%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -15.81% | 4.45% | 52.06% | 138.11% | 225.94% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -15.81% | 4.45% | 52.06% | 138.11% | 225.94% |
| Cost of Revenue | 16.16% | 17.96% | 7.99% | -6.41% | 48.06% |
| Gross Profit | -33.64% | -4.46% | 90.67% | 480.77% | 887.40% |
| SG&A Expenses | -6.10% | 3.45% | 16.20% | 15.95% | -1.65% |
| Depreciation & Amortization | -25.34% | -29.27% | -28.34% | -20.06% | -11.99% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.28% | 5.21% | 5.40% | -6.53% | -21.43% |
| Operating Income | -21.91% | -5.94% | 23.36% | 49.59% | 59.00% |
| Income Before Tax | -130.14% | 34.70% | 63.94% | 70.51% | 80.68% |
| Income Tax Expenses | -- | -- | -- | -- | -23.08% |
| Earnings from Continuing Operations | -130.08% | 34.71% | 63.94% | 70.51% | 80.68% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -130.08% | 34.71% | 63.94% | 70.51% | 80.68% |
| EBIT | -21.91% | -5.94% | 23.36% | 49.59% | 59.00% |
| EBITDA | -30.94% | -11.16% | 24.72% | 54.39% | 64.07% |
| EPS Basic | -113.82% | 45.12% | 70.05% | 76.58% | 84.65% |
| Normalized Basic EPS | -133.87% | -121.93% | 7.91% | 49.81% | 81.29% |
| EPS Diluted | -113.82% | 45.12% | 70.05% | 76.58% | 85.21% |
| Normalized Diluted EPS | -133.87% | -121.93% | 7.91% | 49.81% | 80.37% |
| Average Basic Shares Outstanding | 13.89% | 12.92% | 16.25% | 22.95% | 26.72% |
| Average Diluted Shares Outstanding | 13.89% | 12.92% | 16.25% | 22.95% | 19.60% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |